Ron S. Gejman

Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

Yasin Şenbabaoğlu, Ron S. Gejman, Andrew Winer et al. · Genome biology · 2016 · 1K citations · Full text

Medicine, Immunology, Oncology +17

Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells

Elliott J. Brea, Claire Y. Oh, Eusebio Manchado et al. · Cancer Immunology Research · 2016 · 176 citations · Full text

Life Sciences, Immunology, Oncology +17

Rejection of immunogenic tumor clones is limited by clonal fraction

Ron S. Gejman, Aaron Y. Chang, Heather F. Jones et al. · eLife · 2018 · 135 citations · Full text

Life Sciences, Immunology, Oncology +17

A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens

Aaron Y. Chang, Tao Dao, Ron S. Gejman et al. · Journal of Clinical Investigation · 2017 · 93 citations · Full text

Life Sciences, Immunology, Oncology +17

Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic Platform

Ron S. Gejman, Heather F. Jones, Martin G. Klatt et al. · Cancer Immunology Research · 2020 · 42 citations · Full text

Life Sciences, Immunology, Oncology +17